Chronic Programmed Polypeptide Delivery

We have collected information about Chronic Programmed Polypeptide Delivery for you. Follow the links to find out details on Chronic Programmed Polypeptide Delivery.


Chronic, programmed polypeptide delivery from an implanted ...

    https://www.nature.com/articles/nbt1199
    Mar 12, 2006 · Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nature Biotechnologyvolume 24, pages437–438 (2006) Download Citation. Implanted drug delivery systems are being increasingly used to realize the therapeutic potential of peptides and proteins.Author: James H Prescott, Sara Lipka, Samuel Baldwin, Norman F Sheppard, John M Maloney, Jonathan Coppeta, B...

(PDF) Chronic, programmed polypeptide delivery from an ...

    https://www.researchgate.net/publication/7246498_Chronic_programmed_polypeptide_delivery_from_an_implanted_multireservoir_microchip_device
    Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device

(PDF) Chronic, programmed polypeptide delivery from an ...

    https://www.academia.edu/637180/Chronic_programmed_polypeptide_delivery_from_an_implanted_multireservoir_microchip_device
    Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device

Recent technologies in pulsatile drug delivery systems

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548250/
    Jul 01, 2011 · Pulsatile drug delivery is defined as the rapid and transient release of certain amount of molecules within a short time period immediately after a predetermined off-released period, i.e., lag time, or these systems have a peculiar mechanism of delivering the drug rapidly and completely after a lag time, i.e., a period of no drug release.Author: Deepika Jain, Richa Raturi, Vikas Jain, Praveen Bansal, Ranjit Singh

Wirelessly Controlled Implantable System for On-demand and ...

    https://www.nature.com/articles/s41598-019-41430-8
    Mar 21, 2019 · We propose a wirelessly controlled implantable system for on-demand and pulsatile insulin delivery with a more convenient and safer strategy than …Author: Seung Ho Lee, Joong Woo Ahn, Yong Chan Cho, Se Na Kim, Cheol Lee, Gi Won Ku, Young Bin Choy, Hee Cha...

First-in-Human Testing of a Wirelessly Controlled Drug ...

    https://stm.sciencemag.org/content/4/122/122ra21.full
    Feb 22, 2012 · Furthermore, a net increase in bone mineral density requires intermittent or pulsatile hPTH(1–34) delivery, a challenge for implantable drug delivery products. The microchip-based devices, containing discrete doses of lyophilized hPTH(1–34), were implanted in eight osteoporotic postmenopausal women for 4 months and wirelessly programmed to release doses from the device …Author: Robert Farra, Norman F. Sheppard, Laura McCabe, Robert M. Neer, James M. Anderson, John T. Santini, ...

Overview of microneedle system: a third generation ...

    https://link.springer.com/article/10.1007%2Fs00542-014-2233-5
    Jun 13, 2014 · Transdermal drug delivery has given cardinal contribution to medical practices. First-generation transdermal delivery of small, lipophilic, low-dose drugs and second-generation delivery systems using chemical enhancers, non-cavitational ultrasound and iontophoresis have also resulted in various clinical products provides added functionality.Author: M. S. Giri Nandagopal, Rahul Antony, S. Rangabhashiyam, Nidhin Sreekumar, N. Selvaraju

Drug Delivery Systems - An Overview SpringerLink

    https://link.springer.com/protocol/10.1007%2F978-1-59745-210-6_1
    Drug delivery systems Targeted drug delivery Nanoparticles Nanobiotechnology Personalized medicine Routes of drug administration Drug delivery devices Controlled release Protein/peptide delivery Drug formulations. This is a preview of subscription content, log in to check access.Author: Kewal K. Jain

Microchips in Medicine: Current and Future Applications

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914739/
    Jun 07, 2016 · Applications within chronic conditions such as brain cancer, in which continuous and controllable local drug delivery to a difficult-to-access anatomical location is desired, indicate promising emerging fields for microchip technology.Author: Adam E. M. Eltorai, Henry Fox, Emily McGurrin, Stephanie Guang

Chronic (60-Week) Toxicity Study of DUROS Leuprolide ...

    https://www.researchgate.net/publication/11560743_Chronic_60-Week_Toxicity_Study_of_DUROS_Leuprolide_Implants_in_Dogs
    Chronic (60-Week) Toxicity Study of DUROS Leuprolide Implants in Dogs Article in International Journal of Toxicology 20(6):369-81 · November 2001 with 49 Reads How we measure 'reads'

Searching for Chronic Programmed Polypeptide Delivery?

You can just click the links above. The data is collected for you.

Related Delivery Info